Har magnesiumsulfat (MgSO4) en smertelindrende effekt ved total hoftealloplastik?
Phase 1
- Conditions
- Ptt. som skal have en total hoftealloplastik.
- Registration Number
- EUCTR2004-003777-90-DK
- Lead Sponsor
- Organisation name was not entered
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Voksne ptt. som skal have en total hoftealloplastik.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Påvirket nyre- og/eller leverfunktion.
Hypertension.
Neurologiske lidelser.
Diabetes.
Alkolhol- og/midicinmisbrug.
CalciumBlokkere eller magnesiumbehandling.
Gravide.
Morfinallergi.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Undersøge om magnesiumsulfat har en smertelindrende effekt.;Secondary Objective: Nedsætte opioid forbruget hos de ptt som har fået magnesiumsulfat.;Primary end point(s): Smertescooring ved VAS.<br>Postoperativt opioidforbrug.
- Secondary Outcome Measures
Name Time Method